Study of potential xanthine oxidase inhibitors: In silico and in vitro biological activity

Bangladesh Journal of Pharmacology

Volumn 6, Issue 2, 2011, Pages 117-123

  Umamaheswari, Muthuswamy ^a   Madeswaran, Arumugam ^a   Asokkumar, Kuppusamy ^a   Sivashanmugam, Thirumalaisamy ^a   Subhadradevi, Varadharajan ^a   Jagannath, Puliyath ^a  

^a SRI RAMAKRISHNA INSTITUTE OF PARAMEDICAL SCIENCES   (India)

Author keywords

Allopurinol; Autodock 4.2; Dockingenzyme kinetics; Xanthine oxidase

Indexed keywords

1,2 NAPHTHOQUINONE; 1,4 NAPHTHOQUINONE; ALLOPURINOL; COUMARIN DERIVATIVE; FERULIC ACID; GALLIC ACID; PHLOROGLUCINOL; POLYPHENOL DERIVATIVE; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOLOGICAL ACTIVITY; COMPUTER MODEL; COMPUTER PROGRAM; DRUG MECHANISM; ENZYME INHIBITION; GOUT; HUMAN; IC 50; IN VITRO STUDY;

EID: 84863771047     PISSN: 1991007X     EISSN: 19910088     Source Type: Journal    
DOI: 10.3329/bjp.v6i2.9175     Document Type: Article

References (23)

1. Azam F, Prasad MVV, Thangavel N. Molecular docking studies of 1-(substituted phenyl)-3-(naphtha [1,2-d] thiazol -2-yl) urea/thiourea derivatives with human adenosine A2A receptor. Bioinformation. 2011; 6: 330-34.
2. Borges F, Feranandes E, Roleira F. Progress towards the discovery of xanthine oxidase inhibitors. Curr Med Chem. 2002; 9: 195-217.
3. Breda A, Basso LA, Santos DS, de Azevedo Jr WF. Virtual screening of drugs: Score functions, docking, and drug design. Curr Computer-Aided Drug Design 2008; 4: 265-72.
4. Cavasotto CN, Abagyan RA. Protein flexibility in ligand docking and virtual screening to protein kinases. J Mol Biol. 2004; 12: 209-25.
5. Chang MW, Ayeni C, Breuer S. Virtual screening for HIV protease inhibitors: A comparison of AutoDock 4 and vina. PLoS ONE. 2010; 5: 119-55.
6. Goodsell DS, Morris GM, Olson AJ. Automated docking of flexible ligands: Applications of Autodock. J Mol Recog. 1996; 9: 1-5.
7. Hediger AM. Molecular physiology of urate transport. Physiol. 2005; 20: 125-33.
8. Khodade P, Prabhu R, Chandra N. Parallel implementation of Autodock. J App Crystal. 2007; 40: 598-99.
9. Kimura Y, Ito H, Ohnishi R, Hatano T. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol. 2010; 48: 429-35.
10. Konc J, Konc JT, Penca M, Janezic M. Binding-sites prediction assisting protein-protein docking. Acta Chim Slov. 2011; 58: 396-401.
11. Morris G, Goodsell D, Halliday R. Automated docking using Lamarckian genetic algorithm and an empirical binding free energy function. J Comp Chem. 1998; 19: 1639-62.
12. Niu Y, Zhu H, Liu J, Fan H, Sun L, Lu W, Liu X, Li L. 3,5,2',4'-Tetrahydroxychalcone, a new non-purine xanthine oxidase inhibitor. Chem Biol Inter. 2011; 189: 161-66.
13. Pacher P, Mabley GJ, Soriano GF, Liaudet L, Komjati K, Szabo C. Endothelial dysfunction in aging animals: The role of poly(ADP-ribose) polymerase activation. Br J Pharmacol. 2002; 135: 1347-50.
14. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effect of xanthine oxidase inhibitors: Renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006; 58: 87-114.
15. Park H, Lee J, Lee S. Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins. 2006; 65: 549-54.
16. Symons CRM, Taiwo AF, Petersen LR. Electron addition to xanthine oxidase. An electron spins resonance study of the effects of ionizing radiation. J Chem Soci. 1989; 85: 4063-74.
17. Umamaheswari M, Asokkumar K, Sivashanmugam AT, Remyaraju A, Subhadradevi V, Ravi TK. In vitro xanthine oxidase inhibitory activity of the fractions of Erythrina stricta Roxb. J Ethnopharmacol. 2009; 124: 646-48.
18. Umamaheswari M, Chatterjee TK. Hypouricemic and xanthine oxidase inhibitory activities of the fractions of Coccinia grandis L.Voigt. OPEM. 2008; 7: 477-84.
19. Umamaheswari M, Madeswaran A, Asokkumar K, Sivashanmugam AT, Subhadradevi V, Jagannath V. Docking studies: Search for possible phytoconstituents for the treatment of gout. Int J Biol Pharm Res. 2012; 3: 6-11.
20. Umamaheswari M, Madeswaran A, Asokkumar K, Sivashanmugam T, Subhadradevi V, Jagannath P. Discovery of potential xanthine oxidase inhibitors using in silico docking studies. Der Pharma Chemica. 2011; 3: 240-47.
21. Unno T, Sugimoto A, Kakuda T. Xanthine oxidase inhibitors from the leaves of Lagerstroemia species (L.) Pers J Ethnopharmacol. 2004; 93: 391-95.
22. Werns SW, Grum CM, Ventura A, Hahn RA, Ho PP, Towner RD, Fantone JC, Schork MA, Lucchesi BR. Xanthine oxidase inhibition does not limit canine infarct size. Circulation 1991; 83: 995-1005.
23. Zhang S, Kumar K, Jiang X. DOVIS: An implementation for high throughput virtual ening using Autodock. BMC Bioinformatics. 2008; 9: 126-28.